Probability

Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028

Retrieved on: 
Wednesday, March 20, 2024
Tendinopathy, Artificiality, Health, Patient, Conditional sentence, History, Artificial intelligence, Lantern, Mantle cell lymphoma, OTCQX, Microsoft HoloLens, Context, Corporation, NEO, Microsoft, Automation, MCL, DHL, Splenic infarction, Diabetes, Risk, PALM, Radiology, Software, Treatment, UiPath, OTCQB, Strategic alliance, Prevalence, Disease, Microsoft Mesh, Hospital, Research, News, WELL, Student, TSX, MPH, Nursing, Machine learning, Diagnosis, TED (conference), OSCE, Growth, Cancer, Trust, Sarcoma, NHL, Appendicitis, Ecosystem, Probability, AIDX, Medical device

A report from MarketsAndMarkets opined that the global AI in medical diagnostics market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028.

Key Points: 
  • A report from MarketsAndMarkets opined that the global AI in medical diagnostics market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028.
  • MarketsAndMarkets continued: “Based on component, the AI in medical diagnostics market is bifurcated into software, services, and hardware.
  • The software segment accounted for the largest share of the global AI in medical diagnostics Market in 2022.
  • The hospitals segment accounted for the largest share of the global AI in medical diagnostics Market in 2022.

Optimove Launches Target Group Discovery to Empower Brands to Instantly Identify Valuable Audience Segments

Retrieved on: 
Friday, March 15, 2024
Consumer, ROI, SVP, Creativity, Machine learning, Software, Marketing, Probability, Retail

Target Group Discovery is powered by OptiGenie, Optimove’s AI-powered, Customer-Led Marketing assistant.

Key Points: 
  • Target Group Discovery is powered by OptiGenie, Optimove’s AI-powered, Customer-Led Marketing assistant.
  • Before Target Group Discovery, brands spent significant time and resources to optimize target, segment, and personalize marketing from their vast amounts of customer data.
  • Target Group Discovery slashes that time spent to milliseconds empowering marketers to efficiently leverage their customer data for rapid segmentation and insights.
  • The ability to identify valuable audience segments in an instant will save brands money, hundreds of man-hours, and other resources.

TAYLOR FARMS PACIFIC RECALLS KROGER BRAND READY-TO-EAT APPLE WALNUT WITH CHICKEN SALAD BOWL PRODUCTS DUE TO MISBRANDING AND UNDECLARED ALLERGEN

Retrieved on: 
Thursday, March 14, 2024
USDA, Meat, CHICKEN, Poultry, FSIS, TDD, Office for Civil Rights, Death, Civil and political rights, Probability, Food safety, RTE, Independence Avenue, Human

Taylor Farms Pacific, a Tracy, Calif. establishment, is recalling approximately 19,976 pounds of ready-to-eat (RTE) apple walnut with chicken salad bowl products due to misbranding and undeclared wheat allergen, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.

Key Points: 
  • Taylor Farms Pacific, a Tracy, Calif. establishment, is recalling approximately 19,976 pounds of ready-to-eat (RTE) apple walnut with chicken salad bowl products due to misbranding and undeclared wheat allergen, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.
  • The RTE apple walnut with chicken salad bowl products were produced from Feb. 28, 2024, through March 9, 2024.
  • clear plastic bowl containers with “kroger APPLE WALNUT WITH CHICKEN SALAD KIT FOR ONE” with use by dates of 03/12/24 through 03/22/24, lot codes TFPM059B41, TFPM060B41, TFPM061A41, TFPM062A41, TFPM063B41, TFPM064A41, TFPM064B41, TFPM065A41, TFPM066A41, TFPM067A41, TFPM068A41, TFPM069B42, and TFPM071A41.
  • The products subject to recall bear establishment number “P-34013” below the use by date and lot code.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Plug Power Inc. (PLUG) Investors

Retrieved on: 
Friday, April 5, 2024
Class Action Lawsuit, Professional Services, Legal, GPM, Defendant, News, Alpha, Plug, Suite, Hydrogen, GAAP, Probability, Court

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between May 9, 2023 and January 16, 2024, inclusive (the “Class Period”).

Key Points: 
  • Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between May 9, 2023 and January 16, 2024, inclusive (the “Class Period”).
  • Plug investors have until May 21, 2024 to file a lead plaintiff motion.
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Plug Power Inc. (PLUG) Investors

Retrieved on: 
Friday, April 5, 2024
Class Action Lawsuit, Professional Services, Legal, Law, Telephone, Defendant, News, Alpha, Plug, Suite, Hydrogen, GAAP, Probability, Cryptocurrency

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between May 9, 2023 and January 16, 2024, inclusive (the “Class Period”).

Key Points: 
  • Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between May 9, 2023 and January 16, 2024, inclusive (the “Class Period”).
  • Plug investors have until May 21, 2024 to file a lead plaintiff motion.
  • Investors suffering losses on their Plug investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Plug Power Inc. (PLUG) Investors

Retrieved on: 
Friday, April 5, 2024
Class Action Lawsuit, Professional Services, Legal, Law, Defendant, News, Alpha, Plug, Suite, Hydrogen, GAAP, Probability, Court, Person, Cryptocurrency

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between May 9, 2023 and January 16, 2024, inclusive (the “Class Period”).

Key Points: 
  • The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG ) securities between May 9, 2023 and January 16, 2024, inclusive (the “Class Period”).
  • Plug investors have until May 21, 2024 to file a lead plaintiff motion.
  • If you are a shareholder who suffered a loss, click here to participate.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Triple-I: 2024 Atlantic Hurricane Season Forecast to be ‘Very Active’

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Insurance, Natural Disasters, Environment, Storm, Emerald, Season, Drainage, Tropical Storm Ophelia, Florida Panhandle, Atmospheric science, Insurance Information Institute, Policy, Information International, Inc., CSU, Wind, Water, Klotzbach, Family, Probability, NFIP, Drinking water, Property insurance

A very active tropical cyclone season is projected for 2024 in the Atlantic basin, according to a forecast released today by Colorado State University’s (CSU) Department of Atmospheric Science.

Key Points: 
  • A very active tropical cyclone season is projected for 2024 in the Atlantic basin, according to a forecast released today by Colorado State University’s (CSU) Department of Atmospheric Science.
  • Major hurricanes are defined as those with wind speeds reaching Category 3, 4 or 5 on the Saffir-Simpson Hurricane Wind Scale .
  • It was the third hurricane, and second major hurricane, to make a Florida landfall over the past two seasons.
  • A warmer-than-normal tropical Atlantic provides a more conducive dynamic and thermodynamic environment for hurricane formation and intensification.

Viz.ai® Announces Three New Studies Supporting Viz HCM™ Module for the Detection and Management of Suspected Hypertrophic Cardiomyopathy

Retrieved on: 
Wednesday, April 3, 2024
Health, Technology, Hospitals, Health Technology, Software, Artificial Intelligence, Cardiology, Deep learning, FACC, Harvard Medical School, Machine learning, Cone Health Women's Hospital, PPV, Innovation, Algorithm, Artificiality, Assistant, Disease, Associate, Patient, Atlantic Health System, Triage, Salem Hospital, AI, Viz, American College, Massachusetts General Hospital, HCM, Hospital, Hypertrophic cardiomyopathy, Senior counsel, Sports cardiology, Hypertrophy, Medical director, Probability, FDA, ACC, ECG, Mass, Medical imaging

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in cardiology care.

Key Points: 
  • Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in cardiology care.
  • The Viz HCM module is the first and only AI algorithm cleared by the FDA for HCM.
  • The study found that Viz HCM performance in suspected HCM detection was consistent across various racial backgrounds with a sensitivity of 68.4% and specificity of 99.1%.
  • This validates the effectiveness of relevance score sorting for prioritizing higher probability HCM-positive patients identified by deep-learning algorithms analyzing ECG data.

Global Cell and Gene Therapy Markets Report 2024-2028: Focus on Zolgensma, Yescarta, Kymriah, Abecma, Maci, Tecartus, Epicel - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 3, 2024
Health, Genetics, Growth, PTC Therapeutics, Prevalence, Gene editing, ESG, CSL Behring, Roche, Etranacogene dezaparvovec, Gene, Gilead Sciences, Cancer, Eladocagene exuparvovec, Therapy, CRISPR, Mallinckrodt, PTC, Probability, BLA, Pharmaceutical industry

The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering.
  • The Global Cell and Gene Therapy Market is expected to grow at a compound annual growth rate (CAGR) of 26.40% from 2023 through 2028.
  • The scope of this study encompasses an investigation of the cell and gene therapy market.
  • The report analyzes cell and gene therapy market based on therapy type, product, application, and region.

KBRA Assigns Preliminary Ratings to FREMF 2024-K755 and Freddie Mac Structured Pass-Through Certificate Series K-755

Retrieved on: 
Tuesday, April 2, 2024
Professional Services, Finance, KBRA, CMBS, NCF, Probability, Freddie Mac, SPCS

KBRA is pleased to announce the assignment of preliminary ratings to four classes of FREMF Series 2024-K755 mortgage pass-through certificates and three classes of Freddie-Mac structured pass-through certificates (SPCs), Series K-755.

Key Points: 
  • KBRA is pleased to announce the assignment of preliminary ratings to four classes of FREMF Series 2024-K755 mortgage pass-through certificates and three classes of Freddie-Mac structured pass-through certificates (SPCs), Series K-755.
  • Freddie Mac will guarantee six classes of certificates issued in the underlying Series 2024-K755 securitization and will deposit the guaranteed underlying certificates into a separate trust that will issue the SPCs.
  • The underlying transaction is collateralized by 34 fixed-rate multifamily mortgage loans.
  • The assets are located in 18 states, with the three largest concentrations in Florida (21.1%), Pennsylvania (10.5%), and Texas (10.5%).